Skip to main content
OpenTrials

Clinical trial condition

Esophageal Neoplasms

Explore clinical trials studying Esophageal Neoplasms. Study availability and eligibility vary by location and protocol.

1,231 public trials 309 recruiting studies
Refine in advanced search Browse all conditions

Esophageal Neoplasms trial results

Active, Not Recruiting

Cola Ingestion for Esophageal Bolus Impaction

NCT06652620

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +7 more
Locations
  • Fudan University Shanghai Cancer Center Xiamen Hospital Xiamen, Fujian, China
  • The Northern Jiangsu People's Hospital Yangzhou, Jiangsu, China
  • First People's Hospital Jingdezhen, Jiangxi, China
  • Fudan University Shanghai Cancer Center Shanghai, China
View Trial Details
Active, Not Recruiting

A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer

NCT04757363

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer

NCT07448493

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +17 more
Locations
  • Gomel Regional Clinical Oncology Dispensary (OKOD) Homyel, Belarus
  • Kaliningrad Regional Clinical Oncology Center Kaliningrad, Russia
  • Moscow Regional Oncology Hospital No. 62 Krasnogorsk, Russia
  • A.S. Loginov Moscow Clinical Scientific Center Moscow, Russia
View all 15 locations
View Trial Details
Active, Not Recruiting

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors

NCT05438420

Conditions
Cervical Cancer, Digestive System Diseases, Digestive System Neoplasms, +25 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • CHA Bundang Medical Center Seongnam-si, South Korea
  • Asan Medical Center Seoul, South Korea
View Trial Details
Active, Not Recruiting

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

NCT04430738

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Biliary Tract Diseases, +28 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • University of Colorado Denver CTO(CTRC) Aurora, Colorado, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) Aurora, Colorado, United States
View all 27 locations
View Trial Details

Related conditions